CDMO Profile

COMSER

COMSER Contract Manufacturing & Development (CDMO) Profile

We help early-stage biopharmaceutical and biotech companies to overcome the challenges of product formulation and lyophilization process development for a smooth transition to clinical trials and GMP manufacturing offering contract development and manufacturing services.

COMSER provides services to the biopharmaceutical and biotechnology industries with contract services such as product development and formulation, lyophilization process design & optimization, contract manufacturing, GMP qualification and validation of equipment and manufacturing processes, audits to critical providers and high value training.

CDMO Services:
Finished Dosage Forms (Small Molecule Drugs); Biologics Lyophilized amps/vials Formulation Development; Process Development Antibodies; Antibody-drug conjugate (ADC); Fusion Proteins; Recombinants + other Proteins; mRNA Vaccines; Protein Vaccines

Year Founded: 2009

Head Office: Terrassa, Spain

Number of Facilities: 1-2

Facility locations: Europe

Website: Visit the COMSER website

Linkedin: Connect on Linkedin

Current Capacity: Offering contract manufacturing from 2026 onwards.

Sign up to the free weekly newsletter for all the latest news, resources and podcasts in contract manufacturing.  Register here

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

INFOGRAPHIC

Download the latest infographic summarising key players in Small Molecule, Biologics and Cell & Gene Therapies.

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.